Skylight Health Group Inc (SHG:CN) (SHGFF) PT Raised to Cdn$2.10 at Mackie Research
- Wall Street ends mixed despite bumper big-bank earnings
- Coinbase (COIN) Soars 52% in Public Debut
- Thermo Fisher Scientific (TMO) Nears Deal to Buy PPD, Inc. (PPD) for More Than $15 Billion -DJ
- JPMorgan (JPM) Reports a Q1 Beat on Revenue and Profit Fueled by Release of $5.2 Billion Reserved for Bad Loans; Shares Slightly Down
- Dell Technologies (DELL) Announces Planned VMware (VMW) Spin-Off
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Mackie Research analyst Yue Ma raised the price target on Skylight Health Group Inc (SHG:CN) (OTC: SHGFF) to Cdn$2.10 (from Cdn$1.90) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tenaris S.A. (TEN:IM) (TS) PT Raised to EUR9 at Jefferies
- TMX Group Ltd (X:CN) (TMXXF) PT Raised to Cdn$152 at Scotiabank
- Regis Resources Ltd. (RRL:AU) (RGRNF) PT Lowered to AUD3.40 at Citi
Create E-mail Alert Related CategoriesAnalyst PT Change, Intl Ratings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!